These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Newly diagnosed and previously known diabetes mellitus and 1-year outcomes of acute myocardial infarction: the VALsartan In Acute myocardial iNfarcTion (VALIANT) trial. Aguilar D, Solomon SD, Køber L, Rouleau JL, Skali H, McMurray JJ, Francis GS, Henis M, O'Connor CM, Diaz R, Belenkov YN, Varshavsky S, Leimberger JD, Velazquez EJ, Califf RM, Pfeffer MA. Circulation; 2004 Sep 21; 110(12):1572-8. PubMed ID: 15364810 [Abstract] [Full Text] [Related]
6. Chronic kidney disease, cardiovascular risk, and response to angiotensin-converting enzyme inhibition after myocardial infarction: the Survival And Ventricular Enlargement (SAVE) study. Tokmakova MP, Skali H, Kenchaiah S, Braunwald E, Rouleau JL, Packer M, Chertow GM, Moyé LA, Pfeffer MA, Solomon SD. Circulation; 2004 Dec 14; 110(24):3667-73. PubMed ID: 15569840 [Abstract] [Full Text] [Related]
7. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure. Anand IS, Bishu K, Rector TS, Ishani A, Kuskowski MA, Cohn JN. Circulation; 2009 Oct 20; 120(16):1577-84. PubMed ID: 19805651 [Abstract] [Full Text] [Related]
8. Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarction. Jose P, Skali H, Anavekar N, Tomson C, Krumholz HM, Rouleau JL, Moye L, Pfeffer MA, Solomon SD. J Am Soc Nephrol; 2006 Oct 20; 17(10):2886-91. PubMed ID: 16928807 [Abstract] [Full Text] [Related]
11. Impact of diabetes on mortality in patients with myocardial infarction and left ventricular dysfunction. Murcia AM, Hennekens CH, Lamas GA, Jiménez-Navarro M, Rouleau JL, Flaker GC, Goldman S, Skali H, Braunwald E, Pfeffer MA. Arch Intern Med; 2004 Nov 08; 164(20):2273-9. PubMed ID: 15534166 [Abstract] [Full Text] [Related]
14. Prediction of cardiovascular outcome by estimated glomerular filtration rate and estimated creatinine clearance in the high-risk hypertension population of the VALUE trial. Ruilope LM, Zanchetti A, Julius S, McInnes GT, Segura J, Stolt P, Hua TA, Weber MA, Jamerson K, VALUE Investigators. J Hypertens; 2007 Jul 08; 25(7):1473-9. PubMed ID: 17563571 [Abstract] [Full Text] [Related]
15. Prognosis in diabetic patients with acute myocardial infarction treated invasively is related to renal function. Kowalczyk J, Lenarczyk R, Strojek K, Zielinska T, Gumprecht J, Sedkowska A, Kukulski T, Swierad M, Kowalski O, Sredniawa B, Polonski L, Zembala M, Kalarus Z. Med Sci Monit; 2010 Feb 08; 16(2):CR67-74. PubMed ID: 20110917 [Abstract] [Full Text] [Related]
16. The case for chronic kidney disease, diabetes mellitus, and myocardial infarction being equivalent risk factors for cardiovascular mortality in patients older than 65 years. Rashidi A, Sehgal AR, Rahman M, O'Connor AS. Am J Cardiol; 2008 Dec 15; 102(12):1668-73. PubMed ID: 19064021 [Abstract] [Full Text] [Related]
17. Renal dysfunction in acute stroke: an independent predictor of long-term all combined vascular events and overall mortality. Tsagalis G, Akrivos T, Alevizaki M, Manios E, Stamatellopoulos K, Laggouranis A, Vemmos KN. Nephrol Dial Transplant; 2009 Jan 15; 24(1):194-200. PubMed ID: 18728156 [Abstract] [Full Text] [Related]
18. Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design. Parving HH, Brenner BM, McMurray JJ, de Zeeuw D, Haffner SM, Solomon SD, Chaturvedi N, Ghadanfar M, Weissbach N, Xiang Z, Armbrecht J, Pfeffer MA. Nephrol Dial Transplant; 2009 May 15; 24(5):1663-71. PubMed ID: 19145003 [Abstract] [Full Text] [Related]